SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-22-005187
Filing Date
2022-08-01
Accepted
2022-08-01 08:01:02
Documents
64
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cmpx20220630_10q.htm   iXBRL 10-Q 854750
2 EXHIBIT 31.1 ex_397305.htm EX-31.1 12077
3 EXHIBIT 31.2 ex_397306.htm EX-31.2 11539
4 EXHIBIT 32.1 ex_397307.htm EX-32.1 4413
5 EXHIBIT 32.2 ex_397308.htm EX-32.2 4665
6 EXHIBIT 99.1 ex_398690.htm EX-99.1 97186
12 compasslogo.jpg GRAPHIC 13004
13 ctxschema.jpg GRAPHIC 59714
14 duration.jpg GRAPHIC 86480
15 tumordecline.jpg GRAPHIC 45841
  Complete submission text file 0001171843-22-005187.txt   4803219

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA cmpx-20220630.xsd EX-101.SCH 39984
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cmpx-20220630_cal.xml EX-101.CAL 34666
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cmpx-20220630_def.xml EX-101.DEF 256404
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmpx-20220630_lab.xml EX-101.LAB 239919
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmpx-20220630_pre.xml EX-101.PRE 286139
58 EXTRACTED XBRL INSTANCE DOCUMENT cmpx20220630_10q_htm.xml XML 638259
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39696 | Film No.: 221122836
SIC: 2836 Biological Products, (No Diagnostic Substances)